Julia Kerschbaum
Innsbruck Medical University
Internal medicineIntensive care medicineKidney diseaseDiabetes mellitusMedicine
What is this?
Publications 29
We thank Dr Wallace et al for their response to our recently published article ‘Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis’, highlighting some methodological limitations of our study.1 2 One of the limitations mentioned by Wallace and colleagues is the inclusion of incident and prevalent cases and since only 15 out of 192 patients were incident cases, generalisability of our ...
1 CitationsSource
#1Maria Pippias (PHRI: Public Health Research Institute)H-Index: 7
#2Kitty J. Jager (PHRI: Public Health Research Institute)H-Index: 53
Last. Vianda S. Stel (PHRI: Public Health Research Institute)H-Index: 29
view all 11 authors...
Living kidney donation represents the optimal renal replacement therapy, but recent data suggest an increased long-term renal risk for the donor. Here, we evaluated the risk for reduced estimated glomerular filtration rate (eGFR), death, and major cardiovascular events such as nonfatal myocardial infarction or cerebrovascular event including TIA (transient ischemic attack) and stroke in 225 donors, who underwent pre-donation examinations and live donor nephrectomy between 1985 and 2014 at our ce...
#1David ZweikerH-Index: 4
#2Thomas LambertH-Index: 9
Last. Robert ZweikerH-Index: 24
view all 25 authors...
Objectives:Three recently published sham-controlled studies proved the efficacy of renal denervation (RDN) in hypertensive patients. The study presented here analyzed a nationwide multicentre registry database to clarify which patient subgroups benefit most from radiofrequency RDN.Methods:This is a
Belatacept is an attractive option for immunosuppression after renal transplantation. Renal allograft function is superior when compared to calcineurin inhibitor (CNI) based therapy in “de novo” treated patients and it has also been proposed that individuals at high cardiovascular (CV) risk may benefit most. In this retrospective cohort study, we assessed the efficacy and safety of treating patients at high cardiovascular risk with Belatacept (n = 34, for 1194 observation months) when compared t...
#1Paul PercoH-Index: 24
#2Wenjun JuH-Index: 21
Last. Michael A. RudnickiH-Index: 83
view all 9 authors...
1 CitationsSource
Abstract Aging is a major driver for chronic kidney disease (CKD) and the counterbalancing of aging processes holds promise to positively impact disease development and progression. In this study we generated a signature of renal age-associated genes (RAAGs) based on six different data sources including transcriptomics data as well as data extracted from scientific literature and dedicated databases. Protein abundance in renal tissue of the 634 identified RAAGs was studied next to the analysis o...
#1Susanne EderH-Index: 11
#2Johannes LeiererH-Index: 9
Last. Gert MayerH-Index: 33
view all 11 authors...
Background: The number of patients with type 2 diabetes mellitus and diabetes mellitus–associated chronic kidney disease varies considerably between countries. Next to differences in genetic as well as life style risk factors, varying practices in medical care delivery might cause this diversity. Method: The PROVALID study recruited 4000 patients with type 2 diabetes mellitus at the primary level of healthcare in five European countries (Austria, Hungary, The Netherlands, Poland and Scotland). B...
1 CitationsSource
Objective We aimed to assess risk factors for the development of severe infection in patients with antineutrophil cytoplasm antibody-associated vasculitis (AAV) receiving rituximab. Methods 192 patients with AAV were identified. Univariate and multivariate analyses were performed to identify risk factors for severe infection following rituximab. Severe infections were classified as grade ≥3 as proposed by the Common Terminology Criteria for Adverse Events V.4.0. Results 95 severe infections were...
9 CitationsSource